Literature DB >> 11587066

Cholecystokinin cholescintigraphy: clinical indications and proper methodology.

H A Ziessman1.   

Abstract

Cholecystokinin is a useful diagnostic adjunct to cholescintigraphy. Clinical indications include contracting the gallbladder before cholescintigraphy in patients fasting greater than 24 hours, during cholescintigraphy to diagnose sphincter of Oddi dysfunction, and after cholescintigraphy to exclude acute acalculous cholecystitis, differentiate common duct obstruction from normal variation, and to confirm the diagnosis of chronic acalculous cholecystitis. Proper methodology is mandatory for a diagnostically useful test. Data presented shows that a 3-minute infusion of 0.01 or 0.02 microg/kg is nonphysiologic and often results in ineffective contraction similar to that seen with a bolus infusion. Normal gallbladder ejection (GBEF) values cannot be established using a 3-minute infusion because of the wide variability in response. Instead, infusions of 30 or 60 minutes are required. Normal GBEF values have been established for these methods and are 30% and 40%, respectively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587066     DOI: 10.1016/s0033-8389(05)70325-0

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  7 in total

1.  Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates.

Authors:  Mei Tian; Kazuma Ogawa; Richard Wendt; Uday Mukhopadhyay; Julius Balatoni; Nobuyoshi Fukumitsu; Rajesh Uthamanthil; Agatha Borne; David Brammer; James Jackson; Osama Mawlawi; Bijun Yang; Mian M Alauddin; Juri G Gelovani
Journal:  J Nucl Med       Date:  2011-05-13       Impact factor: 10.057

2.  A novel method for the determination of biliary clearance in humans.

Authors:  Giulia Ghibellini; Brendan M Johnson; Richard J Kowalsky; William D Heizer; Kim L R Brouwer
Journal:  AAPS J       Date:  2004-11-23       Impact factor: 4.009

3.  Acalculous gallbladder disease: the outcomes of treatment by laparoscopic cholecystectomy.

Authors:  M Ahmed; R Diggory
Journal:  Ann R Coll Surg Engl       Date:  2011-04       Impact factor: 1.891

Review 4.  Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential.

Authors:  Marc J Berna; Jose A Tapia; Veronica Sancho; Robert T Jensen
Journal:  Curr Opin Pharmacol       Date:  2007-11-09       Impact factor: 5.547

5.  Laparoscopic cholecystectomy for biliary dyskinesia: correlation of preoperative cholecystokinin cholescintigraphy results with postoperative outcome.

Authors:  J Bingener; M L Richards; W H Schwesinger; K R Sirinek
Journal:  Surg Endosc       Date:  2004-04-02       Impact factor: 4.584

6.  Reproducibility of gallbladder ejection fraction measured by Fatty meal cholescintigraphy.

Authors:  Kusai M Al-Muqbel; Mohammed N Bani Hani; Mwaffaq A Elheis; Ma'moon H Al-Omari
Journal:  Nucl Med Mol Imaging       Date:  2010-10-13

7.  Long-term follow-up of non-operated patients with symptomatic gallbladder stones: a retrospective study evaluating the role of Hepatobiliary scanning.

Authors:  Keun Soo Ahn; Ho-Seong Han; Jai Young Cho; Yoo-Seok Yoon; Chulhan Kim; Won Woo Lee
Journal:  BMC Gastroenterol       Date:  2015-10-15       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.